altretamine has been researched along with Epithelial Neoplasms in 2 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, YS | 1 |
| Nam, JH | 1 |
| Kim, DY | 1 |
| Suh, DS | 1 |
| Kim, JH | 1 |
| Kim, YM | 1 |
| Kim, YT | 1 |
| Griffin, TW | 1 |
| Hunter, RA | 1 |
| Cederbaum, AI | 1 |
| Tak, WK | 1 |
| Ward, AD | 1 |
| Schwartz, JH | 1 |
| Halpin, TF | 1 |
| Strauss, GM | 1 |
| Meyer, RN | 1 |
| Liepman, MK | 1 |
2 other studies available for altretamine and Epithelial Neoplasms
| Article | Year |
|---|---|
Hexamethylmelamine as consolidation treatment for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy.
Topics: Altretamine; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dise | 2009 |
Treatment of advanced ovarian cancer with sequential combination chemotherapy.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamid | 1987 |